BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1310 related articles for article (PubMed ID: 16713591)

  • 1. Carbon monoxide released by CORM-3 inhibits human platelets by a mechanism independent of soluble guanylate cyclase.
    Chlopicki S; Olszanecki R; Marcinkiewicz E; Lomnicka M; Motterlini R
    Cardiovasc Res; 2006 Jul; 71(2):393-401. PubMed ID: 16713591
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigation into the mechanism(s) of antithrombotic effects of carbon monoxide releasing molecule-3 (CORM-3).
    Soni H; Jain M; Mehta AA
    Thromb Res; 2011 Jun; 127(6):551-9. PubMed ID: 21376373
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interference of neutrophil-platelet interaction by YC-1: a cGMP-dependent manner on heterotypic cell-cell interaction.
    Liao CH; Cheng JT; Teng CM
    Eur J Pharmacol; 2005 Sep; 519(1-2):158-67. PubMed ID: 16112105
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence for a cyclic GMP-independent mechanism in the anti-platelet action of S-nitrosoglutathione.
    Gordge MP; Hothersall JS; Noronha-Dutra AA
    Br J Pharmacol; 1998 May; 124(1):141-8. PubMed ID: 9630353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of rat platelet aggregation by the diazeniumdiolate nitric oxide donor MAHMA NONOate.
    Homer KL; Wanstall JC
    Br J Pharmacol; 2002 Dec; 137(7):1071-81. PubMed ID: 12429580
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of human platelet aggregation by nitric oxide donor drugs: relative contribution of cGMP-independent mechanisms.
    Sogo N; Magid KS; Shaw CA; Webb DJ; Megson IL
    Biochem Biophys Res Commun; 2000 Dec; 279(2):412-9. PubMed ID: 11118301
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nitric oxide inhibits platelet adhesion to collagen through cGMP-dependent and independent mechanisms: the potential role for S-nitrosylation.
    Irwin C; Roberts W; Naseem KM
    Platelets; 2009 Nov; 20(7):478-86. PubMed ID: 19852686
    [TBL] [Abstract][Full Text] [Related]  

  • 8. YC-1 inhibited human platelet aggregation through NO-independent activation of soluble guanylate cyclase.
    Wu CC; Ko FN; Kuo SC; Lee FY; Teng CM
    Br J Pharmacol; 1995 Oct; 116(3):1973-8. PubMed ID: 8640334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of platelet aggregation by carbon monoxide is mediated by activation of guanylate cyclase.
    Brüne B; Ullrich V
    Mol Pharmacol; 1987 Oct; 32(4):497-504. PubMed ID: 2890093
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Matrix metalloproteinase 2 in tumor cell-induced platelet aggregation: regulation by nitric oxide.
    Jurasz P; Sawicki G; Duszyk M; Sawicka J; Miranda C; Mayers I; Radomski MW
    Cancer Res; 2001 Jan; 61(1):376-82. PubMed ID: 11196190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Matrix metalloproteinase-2 in platelet adhesion to fibrinogen: interactions with nitric oxide.
    Martinez A; Salas E; Radomski A; Radomski MW
    Med Sci Monit; 2001; 7(4):646-51. PubMed ID: 11433190
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Benzodifuroxan as an NO-dependent activator of soluble guanylate cyclase and a novel highly effective inhibitor of platelet aggregation.
    Bussygina OG; Pyatakova NV; Khropov YV; Ovchinnikov IV; Makhova NN; Severina IS
    Biochemistry (Mosc); 2000 Apr; 65(4):457-62. PubMed ID: 10810184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential sensitivity among nitric oxide donors toward ODQ-mediated inhibition of vascular relaxation.
    Tseng CM; Tabrizi-Fard MA; Fung HL
    J Pharmacol Exp Ther; 2000 Feb; 292(2):737-42. PubMed ID: 10640313
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of platelet aggregation by carbon monoxide-releasing molecules (CO-RMs): comparison with NO donors.
    Chlopicki S; Lomnicka M; Fedorowicz A; Grochal E; Kramkowski K; Mogielnicki A; Buczko W; Motterlini R
    Naunyn Schmiedebergs Arch Pharmacol; 2012 Jun; 385(6):641-50. PubMed ID: 22362133
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endothelial cells play an important role in the antiaggregatory effect of nitric oxide.
    Klinge JM; Topf HG; Trusen B; Rauh M; Rascher W; Dötsch J
    Crit Care Med; 2003 Jul; 31(7):2010-4. PubMed ID: 12847397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antithrombotic properties of water-soluble carbon monoxide-releasing molecules.
    Kramkowski K; Leszczynska A; Mogielnicki A; Chlopicki S; Fedorowicz A; Grochal E; Mann B; Brzoska T; Urano T; Motterlini R; Buczko W
    Arterioscler Thromb Vasc Biol; 2012 Sep; 32(9):2149-57. PubMed ID: 22772756
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms of relaxation by carbon monoxide-releasing molecule-2 in murine gastric fundus and jejunum.
    De Backer O; Lefebvre RA
    Eur J Pharmacol; 2007 Oct; 572(2-3):197-206. PubMed ID: 17610869
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nitric oxide and platelet energy metabolism.
    Tomasiak M; Stelmach H; Rusak T; Wysocka J
    Acta Biochim Pol; 2004; 51(3):789-803. PubMed ID: 15448739
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of human platelet aggregation by S-nitrosothiols. Heme-dependent activation of soluble guanylate cyclase and stimulation of cyclic GMP accumulation.
    Mellion BT; Ignarro LJ; Myers CB; Ohlstein EH; Ballot BA; Hyman AL; Kadowitz PJ
    Mol Pharmacol; 1983 May; 23(3):653-64. PubMed ID: 6135148
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of superoxide anion in the inhibitory effect of SIN-1 in thrombin-activated human platelet adhesion.
    Cardoso MH; Morganti RP; Lilla S; Murad F; De Nucci G; Antunes E; Marcondes S
    Eur J Pharmacol; 2010 Feb; 627(1-3):229-34. PubMed ID: 19895807
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 66.